The contract provides recurring revenue visibility for Cana's EU-GMP facility. Monitor for additional contract announcements and future financial disclosures to assess revenue contribution.
Price Chart
Executive Summary
Cosmos Health, through its subsidiary Cana Laboratories, signed a five-year contract manufacturing agreement with Pharmex S.A. to produce three pharmaceutical products totaling 2.86 million units. No financial terms were disclosed, but the deal supports higher utilization of its EU-GMP facility and adds recurring revenue visibility.
Key Facts
- Five-year contract manufacturing agreement with Pharmex S.A. for three products: BETAFUSIN, BOTAFEX, and BUDESODERM.
- Combined volumes of approximately 2.86 million units over the five-year term.
- Manufacturing will occur at Cana Laboratories' EU-GMP-licensed, EMA-certified facility.
- Financial terms of the agreement were not disclosed.
Financial Impact
Five-year contract manufacturing agreement for 2.86 million units; financial terms not disclosed.
Risk Factors
- No financial terms disclosed; contract may be low-margin.
- Pharmex may not meet volume commitments.
- Concentration risk if a few contracts dominate manufacturing revenue.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3313521 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $0.2530 | awaiting T+20 | — | $0.2610 (+3.16%) |
Oct 16, 2026 10d ago | SC 13G/A | $0.3250 | awaiting T+20 | — | $0.2610 (−19.69%) |
Oct 9, 2026 17d ago | 8-K | $0.3496 | awaiting T+20 | — | $0.2610 (−25.34%) |
Sep 3, 2026 7w ago | Press Release | $0.2660 $0.4300 | ▼ −61.65% | ▼ −62.77% | $0.2610 (+1.88%) |
Aug 19, 2026 9w ago | Press Release | $0.1930 | awaiting T+20 | — | $0.2610 (−35.23%) |
Jul 20, 2026 14w ago | Press Release | $0.2303 $0.2050 | ▼ −10.99% | ▼ −15.11% | $0.2610 (+13.33%) |
Jul 17, 2026 14w ago | Press Release | $0.2348 $0.2179 | ▼ −7.20% | ▼ −11.64% | $0.2610 (+11.16%) |
Jul 16, 2026 14w ago | Press Release | $0.2807 $0.2065 | ▼ −26.43% | ▼ −30.05% | $0.2610 (−7.02%) |
Jul 15, 2026 14w ago | Press Release | $0.2785 $0.2071 | ▼ −25.64% | ▼ −27.98% | $0.2610 (−6.28%) |
Jul 14, 2026 14w ago | Press Release | $0.3071 $0.2198 | ▼ −28.43% | ▼ −30.92% | $0.2610 (−15.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers